Advertisement

Topics

Biocad expects Indian approval of rituximab biosimilar soon

08:21 EDT 4 Jul 2017 | thePharmaLetter

India’s Central Drugs Standard Control Organization (CDSCO) has recommended AcellBia, the first rituximab

Original Article: Biocad expects Indian approval of rituximab biosimilar soon

NEXT ARTICLE

More From BioPortfolio on "Biocad expects Indian approval of rituximab biosimilar soon"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...